Tissue Engineering

Stem Cells May Be Viable Solution For Patients With Limited Options For Urologic Reconstruction

Published in Blood Weekly, June 28th, 2001

Embryonic stem cells may become a reliable cell source for patients in need of urologic reconstruction who have limited host tissue, according to Children's Hospital Boston researchers.

Currently, as an alternative to a donated organ, strategies have been developed for replacing diseased or damaged organs by using the patient's own tissue as a base to create a tissue engineered organ in the lab. However, in situations where a patient's organ is so badly diseased that it becomes nearly impossible to take a tissue biopsy from that organ to create a new organ, the availability of pluripotent stem cells, or a colony of many cells, may be beneficial, according to study...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry